COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database

Atrial fibrillation (AF) has been described in COVID-19 patients. Recently, some case reports and US pharmacovigilance analyses described AF onset as a rare adverse event following COVID-19 vaccination. The possible correlation is unclear. We systematically analyzed the reports of AF related to COVI...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruggiero, Rosanna, Donniacuo, Maria, Mascolo, Annamaria, Gaio, Mario, Cappetta, Donato, Rafaniello, Concetta, Docimo, Giovanni, Riccardi, Consiglia, Izzo, Imma, Ruggiero, Donatella, Paolisso, Giuseppe, Rossi, Francesco, De Angelis, Antonella, Capuano, Annalisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295866/
https://www.ncbi.nlm.nih.gov/pubmed/37371680
http://dx.doi.org/10.3390/biomedicines11061584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295866/
https://www.ncbi.nlm.nih.gov/pubmed/37371680
http://dx.doi.org/10.3390/biomedicines11061584

Ejemplares similares